SCHEMBL105471

SCHEMBL105471

CC(=O)[C@@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11031917 1.00
SCHEMBL422046 1.00
SCHEMBL28286550 0.84 TGFBR1 (0.36)
SCHEMBL28286551 0.83 TGFBR1 (0.31)
SCHEMBL12891365 0.76 ALDH1A1 (0.40)
SCHEMBL9500567 0.76 TSHR (0.44)
SCHEMBL17953984 0.76 ALDH1A1 (0.40)
SCHEMBL13410354 0.76 GABRR1 (0.46)
SCHEMBL15681461 0.75
Acetone SCHEMBL31146574 0.75 GABRR1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175530-A1 ANTIBACTERIAL AGENTS ACHAOGEN, INC. 2015-06-25 US disclosed
US-8481546-B2 CGRP receptor antagonist BRISTOL-MYERS SQUIBB COMPANY (US) 2013-07-09 US disclosed
US-8431724-B2 Iejimalid analoga and uses thereof STUDIENGESELLSCHAFT KOHLE MBH (DE) 2013-04-30 US disclosed
US-20120059017-A1 CGRP Receptor Antagonist BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-8076285-B2 Lysobactin amides AICURIS GMBH & CO. KG (DE) 2011-12-13 US disclosed
US-8067455-B2 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof XENOPORT, INC. (US) 2011-11-29 US disclosed
US-7919528-B2 Antibiotic; bactericides GLAXOSMITHKLINE LLC (US) 2011-04-05 US disclosed
US-20100087536-A1 AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS, USES AND CRYSTALLINE FORMS THEREOF XENOPORT, INC. (US) 2010-04-08 US disclosed
US-7619110-B2 Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof XENOPORT, INC. (US) 2009-11-17 US disclosed
US-20090203582-A1 LYSOBACTIN AMIDES BAYER HEALTHCARE AG (DE) 2009-08-13 US disclosed
US-20090186817-A1 PEPTIDE-PEPTIDASE INHIBITOR CONJUGATES AND METHODS OF USING SAME AMYLIN PHARMACEUTICALS, INC. (US) 2009-07-23 US disclosed
US-7507726-B2 Peptide deformylase inhibitors SMITHKLINEBEECHAM CORPORATION (US) 2009-03-24 US disclosed
US-7491712-B1 Process for preparation of paricalcitol and intermediates thereof FORMOSA LABORATORIES, INC. (TW) 2009-02-17 US disclosed
US-20080167302-A1 Peptide Deformylase Inhibitors GLAXOSMITHKLINE LLC 2008-07-10 US disclosed
EP-0119251-A1 HYDROXYVITAMIN D 2? COMPOUNDS AND PROCESS FOR PREPARING THEM WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1984-09-26 EP disclosed
US-4448721-A Hydroxyvitamin D2 compounds and process for preparing same WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1984-05-15 US disclosed
WO-1984001155-A1 HYDROXYVITAMIN D2 COMPOUNDS AND PROCESS FOR PREPARING THEM WISCONSIN ALUMNI RES FOUND (US) 1984-03-29 WO disclosed